According to research report the blood gas analyzer market
was estimated to be USD 506.9 Million in 2016, which would reach USD
636 Million by 2021, growing at a CAGR of 4.6% during 2016 to 2021.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963
The major players in the global blood gas analyzer market are Abbott
Laboratories (U.S.), Alere, Inc. (U.S.), Instrumentation Laboratory
(U.S.), Radiometer (Denmark), Roche Diagnostics (Switzerland), and
Siemens Healthcare (Germany). The top 3 companies together account for a
share of more than 70% of the global market. These players have adopted
several strategies to remain competitive in this space. Enhancement of
existing products, development of new products, collaborations and
agreements are among the top strategies adopted by the leading companies
in blood gas analyzers market.
Companies such as Roche Diagnostics Limited, Nova Biomedical, Abbott
Laboratories, and OPTI Medical Systems, Inc. adopted the strategy of new
product launch to develop novel blood gas analyzers, strengthen their
product portfolios, and address the demands of their customers. In June
2016, Roche Diagnostics launched its blood gas learning application,
namely, Blood Gas Learn Your ABGs. The new app helps in learning and
interpreting arterial blood gases. This enabled the company to enhance
its market visibility. Similarly, Nova launched Stat Profile Prime, a
blood gas analyzer, in May 2014. This testing system can be combined
with Nova’s zero maintenance cartridge technology, which gives faster
and accurate results. The launch of this product helped the company to
expand its product offerings in the point-of-care testing market.
Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=242278963
North America is estimated to dominate the global blood gas analyzer
market in 2016. The large share of this regional segment can primarily
be attributed to the growing prevalence of lifestyle diseases,
increasing number of product approvals, and rising government
initiatives. On the other hand, the Asia-Pacific market is expected to
witness the highest growth during the forecast period, owing to factors
such as growing initiatives by market players and increasing patient
population base in this region.